rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
9
|
pubmed:dateCreated |
1997-10-16
|
pubmed:abstractText |
To study at a molecular level the clonality of interleukin 2 (IL-2) expanded T cell lines derived from rheumatoid nodules. Such cell lines were reported in earlier studies with flow cytometry and antiidiotypic monoclonal antibodies (MAb) to be obligoclonal.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0315-162X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1685-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9292788-Aged,
pubmed-meshheading:9292788-Arthritis, Rheumatoid,
pubmed-meshheading:9292788-Cell Line,
pubmed-meshheading:9292788-Clone Cells,
pubmed-meshheading:9292788-DNA Primers,
pubmed-meshheading:9292788-Flow Cytometry,
pubmed-meshheading:9292788-Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor,
pubmed-meshheading:9292788-Gene Rearrangement, beta-Chain T-Cell Antigen Receptor,
pubmed-meshheading:9292788-Humans,
pubmed-meshheading:9292788-Interleukin-2,
pubmed-meshheading:9292788-Lymphocyte Activation,
pubmed-meshheading:9292788-Male,
pubmed-meshheading:9292788-Polymerase Chain Reaction,
pubmed-meshheading:9292788-Receptors, Antigen, T-Cell, alpha-beta,
pubmed-meshheading:9292788-Rheumatoid Nodule,
pubmed-meshheading:9292788-T-Lymphocytes
|
pubmed:year |
1997
|
pubmed:articleTitle |
Dominant T cell receptor rearrangements in interleukin 2 expanded lymphocytes from rheumatoid nodules suggest antigen driven T cell activation in situ.
|
pubmed:affiliation |
Department of Rheumatology, University Hospital Ghent, Belgium.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|